Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3824767 | Progrès en Urologie | 2013 | 8 Pages |
Abstract
The decrease of sexual desire is one of the symptoms seen in late-onset hypogonadism. The effect of testosterone replacement therapy is more obvious that testosterone is low and there are no other causes of impaired sexual desire. There is no evidence that testosterone therapy increases the risk of prostate cancer, benign prostatic hyperplasia or promotes the clinical expression of subclinical prostate cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
H. Lejeune, Ã. Huyghe, S. Droupy,